World Health Organization Director-General Tedros Adhanom Ghebreyesus said the Ebola outbreak in the Democratic Republic of Congo is very complex but can be stopped.
The situation represents a critical public health challenge because the virus is spreading in an environment destabilized by war and hunger, making traditional containment efforts difficult.
Tedros arrived at the airport in the Democratic Republic of Congo late Thursday to coordinate the response. He said the outbreak is being driven by heavy population displacement resulting from regional conflict and widespread food insecurity [1]. These factors create a volatile environment where health workers struggle to track and treat patients.
"To come here is to really show to the community that they’re not alone," Tedros said [2].
The scale of the crisis has expanded rapidly in recent weeks. There were 256 suspected and confirmed Ebola cases on May 16 [3]. By May 27, that number grew to roughly 1,000 cases [3].
To curb the transmission of the virus, authorities have implemented strict social distancing measures. In northeastern Congo, funeral gatherings are now limited to no more than 50 people [4]. Such restrictions are necessary because Ebola often spreads during traditional burial rites, where contact with the deceased is common.
Tedros said that stopping the outbreak requires a coordinated response and strong community support. He said that while the combination of conflict and disease is challenging, the tools to end the transmission exist if the international community and local leaders work together [1].
“The Ebola outbreak in the Democratic Republic of Congo is very complex but can be stopped.”
The rapid quadrupling of cases in less than two weeks underscores how fragile health infrastructure becomes during regional conflict. When population displacement and food insecurity coincide with a viral outbreak, medical interventions are often hindered by a lack of trust and physical access, meaning the success of the response depends as much on geopolitical stability as it does on clinical treatment.




